PICC

Power Hour Breakout

L4 — Subcutaneous Engineered Stabilzation Device (SESD): added Infection Risk?

Tuesday, September 18
8:00 AM - 9:00 AM
Location: C170
Presentation CE Credits: 1

What role, if any, does the use of a Subcutaneous Engineered Stabilization Device (SESD) relate to CLABSI? Does the use of SQ securement = increased infection? With dislodgement and catheter tip migration having long term consequences, including thrombosis, infection rates and aspects related to vascular preservation, we must continue to find ways to achieve better patient outcomes. Presentation will present data related to 4 years CLABSI rates within an academic medical center.

Learning Objectives:

Mark S. Rowe, MNSc, RNP, VA-BC™

Sr Vascular Access Specialist
University of Arkansas for Medical Sciences (UAMS)

Sr Vascular Access Specialist at the University of Arkansas for Medical Sciences with 30+ years of nursing experience. Local, State, National and international speaker.

Presentation(s):

Send Email for Mark Rowe


Assets

L4 — Subcutaneous Engineered Stabilzation Device (SESD): added Infection Risk?

Audio Slides

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Subcutaneous Engineered Stabilzation Device (SESD): added Infection Risk?